Yamanouchi To Co-Promote BI's Flomax With 335 Sales Reps
This article was originally published in The Pink Sheet Daily
Executive Summary
Yamanouchi will provide 200 primary care reps and 135 more for specialists. Abbott's co-promotion agreement with BI for the benign hyperplasia treatment expires at the end of August.